Goosehead Insurance (GSHD) Earnings Analysis
Goosehead Insurance (GSHD) next reports earnings on 2026-10-28, consensus EPS 0.59 USD. Last quarter (2026-07-22) it beat with EPS 0.64 USD vs 0.474 USD est (+35%). It has beaten estimates in 5/7 recent quarters (71%). Trailing P/E 35.94.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does GSHD next report earnings?
| Next earnings date | 2026-10-28 |
|---|---|
| Consensus EPS estimate | 0.59 USD |
| Revenue estimate | 0.11B |
GSHD earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-07-22 | 0.64 USD | 0.474 USD | +35% | Beat |
| 2026-04-22 | 0.3 USD | 0.2 USD | +50% | Beat |
| 2026-02-17 | 0.64 USD | 0.54 USD | +18.5% | Beat |
| 2025-10-22 | 0.46 USD | 0.47 USD | -2.1% | Miss |
| 2025-07-23 | 0.49 USD | 0.53 USD | -7.5% | Miss |
| 2025-02-24 | 0.79 USD | 0.41 USD | +92.7% | Beat |
| 2024-07-24 | 0.42 USD | 0.4 USD | +5% | Beat |
Beat rate: 5/7 (71%) over reported quarters with consensus data.
GSHD valuation and analyst view
| Trailing P/E | 35.94 |
|---|---|
| Trailing EPS | 1.471 USD |
| Price / book | -10.97 |
| Dividend yield | 0.00% |
| Market cap | 1.99B |
| Analyst consensus | Buy (10 buy / 7 hold / 1 sell) |
| Avg price target | 66.88 USD |
Related research pages
Frequently asked questions
When is Goosehead Insurance (GSHD)'s next earnings date?
Goosehead Insurance is next scheduled to report on 2026-10-28, with a consensus EPS estimate of 0.59 USD and revenue estimate of 0.11B.
Did GSHD beat earnings last quarter?
In its 2026-07-22 report, GSHD posted EPS of 0.64 USD versus a 0.474 USD estimate — a beat of 35%.
What is GSHD's earnings track record?
Over the last 7 reported quarters with consensus data, GSHD beat estimates 5 times (71%).
What is GSHD's current P/E ratio and EPS?
GSHD trades at a trailing P/E of 35.94 on trailing EPS of 1.4710320106702235 USD.
What do analysts rate GSHD?
Analyst consensus is "Buy" across 18 ratings (0 strong buy, 10 buy, 7 hold, 1 sell, 0 strong sell). Average 12-month price target: 66.88 USD.